Stockholders’ Equity |
9 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 | |||
| Equity [Abstract] | |||
| Stockholders’ Equity |
Common Stock Transactions – Fiscal 2024
In July 2023, the Company issued shares of common stock pursuant to a loan agreement for $60,000.
In July 2023, the Company issued shares of common stock pursuant to the Stock Purchase Agreement with Prakat Solutions Inc. for $14,413.
In September 2023, the Company issued shares of common stock related to the acquisition of Watson for $37,500.
In October 2023 the company issued shares of common stock pursuant to a loan agreement for $173,000.
In December 2023, the Company issued shares of common stock related to the acquisition of Watson for $26,500.
In December 2023, the Company issued shares of common stock related to the acquisition of DepTec (SSCe) for $70,667.
In January 2024, the Company reduced the number of authorized shares from 1,000,000,000 to .
In February 2024, the Company issued shares of common stock related to a Company conducted private placement for $604,000.
In February 2024, the Company issued shares of common stock pursuant to consulting agreements resulting in $ in consultancy fees. The fair value of these shares was based upon the quoted closing trading price.
Common Stock Transactions – Fiscal 2023
In July 2022, November 2022, December 2022, March 2023 and June 2023, the Company issued a total of shares of common stock related to the acquisition of DepTec (SSCe).
In July 2022, the Company issued shares of common stock pursuant to a consulting agreement for management services.
In December 2022, March 2023 and April 2023, the Company issued a total of shares of common stock related to the acquisition of Watson.
In September 2022, December 2022, and March 2023, the Company issued a total of shares of common stock related to the acquisition of International Health Group.
In September 2022 and December 2022, the Company issued a total of shares of common stock related to the acquisition of Pacific Stem Business.
During the nine months ended March 31, 2023, the Company issued shares of common stock pursuant to the conversion of $1,475,608 of convertible debt and its related premium and interest expense.
|